These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7299160)

  • 1. Oxamniquine treatment in experimental schistosomiasis mansoni. Biological, morphological and pathological changes induced by divided doses.
    Mikhail EG; Sabet S; Mahran SG; Gaber AA; Soliman AA; Zaki IE; Tadros MB
    J Egypt Soc Parasitol; 1981 Jun; 11(1):33-49. PubMed ID: 7299160
    [No Abstract]   [Full Text] [Related]  

  • 2. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 3. Field use of oral oxamniquine in the treatment of S. mansoni.
    Eyakuze VM; Rutasitara WK; Ndalahwa JB
    East Afr Med J; 1979 Jan; 56(1):22-5. PubMed ID: 436702
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxamniquine dosage in Malawi.
    Teesdale CH; Chitsulo L; Pugh RN
    East Afr Med J; 1984 Jan; 61(1):40-4. PubMed ID: 6745140
    [No Abstract]   [Full Text] [Related]  

  • 5. A fifteen-month study on the efficacy of a single 15 mg/kg dose of oxamniquine (Vansil) in Schistosoma mansoni in an endemic area.
    Nozais JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):52-7, 168-74. PubMed ID: 6256843
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-finding trials of oral oxamniquine in Rhodesia.
    de V Clarke V; Blair DM; Weber MC; Garnett PA
    S Afr Med J; 1976 Oct; 50(46):1867-71. PubMed ID: 996687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis.
    Pugh RN; Teesdale CH
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):877-8. PubMed ID: 6412867
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials with oxamniquine, by oral route, in schistosomiasis mansoni.
    Katz N; Grinbaum E; Chaves A; Zicker F; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):371-7. PubMed ID: 794980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxamniquine on some biological features of schistosomiasis in white mice.
    Hammouda NA; El-Ridi AM; Abu Senna HO; Nasr NT; El-Sawi MF; El-Sawi M; Salama MM
    J Egypt Soc Parasitol; 1983 Jun; 13(1):147-53. PubMed ID: 6631092
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxamniquine (Vansil) in the treatment of Schistosoma mansoni infections in Rhodesia.
    de V Clarke V
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):20-3. PubMed ID: 606374
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

  • 16. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.